Vertex Pharmaceuticals ROI - Return on Investment 2010-2025 | VRTX

Vertex Pharmaceuticals return on investment for the quarter ending March 31, 2025 was -6.19.

  • Vertex Pharmaceuticals average return on investment for 2024 was 3.55, a 84.42% decline from 2023.
  • Vertex Pharmaceuticals average return on investment for 2023 was 22.79, a 13.41% decline from 2022.
  • Vertex Pharmaceuticals average return on investment for 2022 was 26.32, a 6.69% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Vertex Pharmaceuticals ROI - Return on Investment 2010-2025 | VRTX

  • Vertex Pharmaceuticals average return on investment for 2024 was 3.55, a 84.42% decline from 2023.
  • Vertex Pharmaceuticals average return on investment for 2023 was 22.79, a 13.41% decline from 2022.
  • Vertex Pharmaceuticals average return on investment for 2022 was 26.32, a 6.69% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.